BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33744391)

  • 1. Frailty is associated with chronic inflammation and pro-inflammatory monocyte subpopulations.
    Cybularz M; Wydra S; Berndt K; Poitz DM; Barthel P; Alkouri A; Heidrich FM; Ibrahim K; Jellinghaus S; Speiser U; Linke A; Christoph M; Pfluecke C
    Exp Gerontol; 2021 Jul; 149():111317. PubMed ID: 33744391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mon2-monocytes and increased CD-11b expression before transcatheter aortic valve implantation are associated with earlier death.
    Pfluecke C; Wydra S; Berndt K; Tarnowski D; Cybularz M; Jellinghaus S; Mierke J; Ende G; Poitz DM; Barthel P; Heidrich FM; Quick S; Sveric KM; Speiser U; Linke A; Ibrahim K
    Int J Cardiol; 2020 Nov; 318():115-120. PubMed ID: 32413468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD11b expression on monocytes and data of inflammatory parameters after Transcatheter Aortic Valve Implantation in dependence of early mortality.
    Pfluecke C; Wydra S; Berndt K; Tarnowski D; Cybularz M; Barthel P; Linke A; Ibrahim K; Poitz DM
    Data Brief; 2020 Aug; 31():105798. PubMed ID: 32548226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of frailty on health-related quality of life 1 year after transcatheter aortic valve implantation.
    Goudzwaard JA; de Ronde-Tillmans MJAG; van Hoorn FED; Kwekkeboom EHC; Lenzen MJ; van Wiechen MPH; Ooms JFW; Nuis RJ; Van Mieghem NM; Daemen J; de Jaegere PPT; Mattace-Raso FUS
    Age Ageing; 2020 Oct; 49(6):989-994. PubMed ID: 32421189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
    Holierook M; Henstra MJ; Dolman DJ; Chekanova EV; Veenis L; Beijk MAM; de Winter RJ; Baan J; Vis MM; Lemkes JS; Snaterse M; Henriques JPS; Delewi R
    Int J Cardiol; 2024 Mar; 399():131637. PubMed ID: 38065322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frailty in patients undergoing transcatheter aortic valve implantation: a protocol for a systematic review.
    Li Z; Dawson E; Moodie J; Martin J; Bagur R; Cheng D; Kiaii B; John-Baptiste A
    BMJ Open; 2019 Feb; 9(2):e024163. PubMed ID: 30782896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Erasmus Frailty Score is associated with delirium and 1-year mortality after Transcatheter Aortic Valve Implantation in older patients. The TAVI Care & Cure program.
    Goudzwaard JA; de Ronde-Tillmans MJAG; El Faquir N; Acar F; Van Mieghem NM; Lenzen MJ; de Jaegere PPT; Mattace-Raso FUS
    Int J Cardiol; 2019 Feb; 276():48-52. PubMed ID: 30409734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel geriatric assessment frailty score predicts 2-year mortality after transcatheter aortic valve implantation.
    Skaar E; Eide LSP; Norekvål TM; Ranhoff AH; Nordrehaug JE; Forman DE; Schoenenberger AW; Hufthammer KO; Kuiper KK; Bleie Ø; Packer EJS; Langørgen J; Haaverstad R; Schaufel MA
    Eur Heart J Qual Care Clin Outcomes; 2019 Apr; 5(2):153-160. PubMed ID: 30256921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Okoh AK; Chauhan D; Kang N; Haik N; Merlo A; Cohen M; Haik B; Chen C; Russo MJ
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1000-1006. PubMed ID: 28463403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Anand A; Harley C; Visvanathan A; Shah ASV; Cowell J; MacLullich A; Shenkin S; Mills NL
    Eur Heart J Qual Care Clin Outcomes; 2017 Apr; 3(2):123-132. PubMed ID: 28927173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty Status and Outcomes After Transcatheter Aortic Valve Implantation.
    Huded CP; Huded JM; Friedman JL; Benck LR; Lindquist LA; Holly TA; Sweis RN; Ricciardi MJ; Malaisrie SC; Davidson CJ; Flaherty JD
    Am J Cardiol; 2016 Jun; 117(12):1966-71. PubMed ID: 27156828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of administrative database frailty instruments in predicting clinical outcomes and cost for patients undergoing transcatheter aortic valve implantation: a historical cohort study.
    Li Z; Wijeysundera HC; Bagur R; Cheng D; Martin J; Kiaii B; Qiu F; Fang J; John-Baptiste A
    Can J Anaesth; 2023 Jan; 70(1):116-129. PubMed ID: 36577891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement and prognosis of frail patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Li Z; Dawson E; Moodie J; Martin J; Bagur R; Cheng D; Kiaii B; Hashi A; Bi R; Yeschin M; John-Baptiste A
    BMJ Open; 2021 Mar; 11(3):e040459. PubMed ID: 33664067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and mobility predict all-cause mortality in patients 12 months after transcatheter aortic valve implantation.
    Eichler S; Salzwedel A; Harnath A; Butter C; Wegscheider K; Chiorean M; Völler H; Reibis R
    Clin Res Cardiol; 2018 Apr; 107(4):304-311. PubMed ID: 29164390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of frailty on mortality after transcatheter aortic valve implantation.
    Kleczynski P; Dziewierz A; Bagienski M; Rzeszutko L; Sorysz D; Trebacz J; Sobczynski R; Tomala M; Stapor M; Dudek D
    Am Heart J; 2017 Mar; 185():52-58. PubMed ID: 28267475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress-Induced, Piezo-1-Mediated Monocyte Activation.
    Baratchi S; Zaldivia MTK; Wallert M; Loseff-Silver J; Al-Aryahi S; Zamani J; Thurgood P; Salim A; Htun NM; Stub D; Vahidi P; Duffy SJ; Walton A; Nguyen TH; Jaworowski A; Khoshmanesh K; Peter K
    Circulation; 2020 Sep; 142(11):1092-1105. PubMed ID: 32697107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Frailty as an Outcome Predictor After Transcatheter Aortic Valve Implantation.
    Rogers T; Alraies MC; Moussa Pacha H; Bond E; Buchanan KD; Steinvil A; Gai J; Torguson R; Ben-Dor I; Satler LF; Waksman R
    Am J Cardiol; 2018 Apr; 121(7):850-855. PubMed ID: 29422352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic obstructive pulmonary disease and frailty on long-term outcomes and quality of life after transcatheter aortic valve implantation.
    Dziewierz A; Tokarek T; Kleczynski P; Sorysz D; Bagienski M; Rzeszutko L; Dudek D
    Aging Clin Exp Res; 2018 Sep; 30(9):1033-1040. PubMed ID: 29185204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of Frailty to Cost for Patients Undergoing Transcatheter Aortic Valve Implantation.
    Patel JN; Ahmad M; Kim M; Banga S; Asche C; Barzallo M; Mungee S
    Am J Cardiol; 2020 Feb; 125(3):469-474. PubMed ID: 31806209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidimensional geriatric assessment before transcatheter aortic valve implantation in frail elderly patients with one-year follow-up. Cardio-geriatrician collaboration benefits?].
    Damier E; Chidlovskii E; Bertrand B; Dang VM; Vanzetto G; Couturier P
    Ann Cardiol Angeiol (Paris); 2016 Sep; 65(4):250-4. PubMed ID: 27427467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.